ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.

Mary E Olanich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.